The basis for disease‐modifying treatments for Alzheimer's disease: The Sixth Annual Mild Cognitive Impairment Symposium-Reference-Cited by-同舟云学术

The basis for disease‐modifying treatments for Alzheimer's disease: The Sixth Annual Mild Cognitive Impairment Symposium

Published:2009-01 Issue:1 Volume:5 Page:66-74
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Duara Ranjan¹²,Barker Warren¹,Loewenstein David²,Bain Lisa³

Affiliation:

1. Wien Center for Alzheimer's Disease & Memory DisordersMount Sinai Medical CenterMiami BeachFLUSA

2. Department of Medicine and PsychiatryMiller School of MedicineUniversity of MiamiMiami BeachFLUSA

3. Independent science writerElversonPAUSA

Funder

Alzheimer's Association

Dade Community Foundation

Merck

Forest Laboratories

Novartis

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2008.10.006

Reference15 articles.

1. Cyclohexanehexol inhibitors of Aβ aggregation prevent and reverse Alzheimer phenotype in a mouse model

2. Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo

3. Inflammatory markers and the risk of Alzheimer disease: The Framingham Study

4. Inflammatory biomarkers are associated with total brain volume

5. Aggregation of vascular risk factors and risk of incident Alzheimer disease

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metal chelators as part of a strategy for the treatment of neurodegenerative diseases;Trace Elements and Electrolytes;2023-07-01

2. The effects of herbal medicine (Jujadokseo-hwan) on quality of life in patients with mild cognitive impairment: Cost-effectiveness analysis alongside randomized controlled trial;Integrative Medicine Research;2023-03

3. The Potential Influence of Bone-Derived Modulators on the Progression of Alzheimer’s Disease;Journal of Alzheimer's Disease;2019-05-07

4. Cornel iridoid glycoside exerts a neuroprotective effect on neuroinflammation in rats with brain injury by inhibiting NF-κB and STAT3;3 Biotech;2019-05

5. Enriched Environment Significantly Reduced Senile Plaques in a Transgenic Mice Model of Alzheimer’s Disease, Improving Memory;Frontiers in Aging Neuroscience;2018-09-26